Stratification analysis of risk of major adverse cardiovascular events among different group in the model 1 matched population
Any HZ vaccine | No HZ vaccine | ||||
n | No. of event | n | No. of event | HR (95% CI) | |
Age | |||||
50–65 | 28 258 | 1634 | 28 258 | 1968 | 0.80 (0.75 to 0.86) |
>65 | 16 903 | 1859 | 16 903 | 1723 | 0.83 (0.78 to 0.89) |
Sex | |||||
Female | 22 591 | 1559 | 22 591 | 1808 | 0.77 (0.72 to 0.83) |
Male | 20 603 | 1665 | 20 603 | 1995 | 0.74 (0.69 to 0.79) |
Type 1 diabetes | 230 | 10 | 230 | 16 | 0.25 (0.08 to 0.75) |
Type 2 diabetes | 42 503 | 2945 | 42 503 | 3588 | 0.71 (0.68 to 0.75) |
If the patient’s count is 1–10, the results indicate a count of 10.
Model 1 indicates any HZ vaccination versus no HZ vaccination population.
Any vaccine, Shingrix or Zostavax; HZ, herpes zoster.